2024

Articles

• Sýkorová A, Folber F, Polgárová K, Móciková H, Ďuraš J, Steinerová K, Obr A, Heindorfer A, Ladická M, Lukáčová Ľ, Čellárová E, Plameňová I, Belada D, Janíková A, Trněný M, Jančárková T, Procházka V, Vranovský A, Králiková M, Vydra J, Smolej L, Drgoňa Ľ, Sedmina M, Čermáková E, Pytlík R. Several factors that predict the outcome of large B-cell lymphoma patients who relapse/progress after chimeric antigen receptor (CAR) T-cell therapy can be identified before cell administration. Cancer Med. 2024 Sep;13(17):e70138. doi: 10.1002/cam4.70138. PMID: 39248284; PMCID: PMC11382134.
• Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U, Herhaus P, Benedetti F, Sonnevi K, Hanoun C, Hänel M, Dierlamm J, Pott C, Klapper W, Gözel D, Schmidt C, Unterhalt M, Ladetto M, Hoster E. Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. Lancet. 2024 May 25;403(10441):2293-2306. doi: 10.1016/S0140-6736(24)00184-3. Epub 2024 May 2. PMID: 38705160.

ASH abstracts

• Vodicka P, Benesova K, Janikova A, Belada D, Hruskova A, Mocikova H, et al. The Survival Improvement of Transplant-Eligible Primary CNS Lymphoma Patients within Last 15 Years. Blood. 2024;144:1697.
• Vodicka P, Benesova K, Janikova A, Belada D, Hanackova V, Mocikova H, et al. PCNSL Patients Treated with the Matrix Regimen in the Real World Have Similar Outcome to Those in the IELSG 32 Trial. Blood. 2024;144:1711.
• Masar M, Vodicka P, Hricko S, Janikova A, Benesova K, Salek D, et al. Validation of the CNS-IPI-C Prognostic Model in Patients with Systemic DLBCL in the Real World. Blood. 2024;144:3081.